English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52302352    在线人数 :  1051
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至: [ 中文 ] [ 数字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
请输入前几个字:   

显示项目 244831-244880 / 2348487 (共46970页)
<< < 4892 4893 4894 4895 4896 4897 4898 4899 4900 4901 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
東海大學 2009 Cetrarioid lichen genera and species in NE China Lai, M.-J., Chen, X.-L., Qian, Z.-G., Xu, L., Anti, T.
臺大學術典藏 2021-09-09T02:26:28Z Cette belle viande: Cézanne's bathers of the Impressionist years, 1872-1880 CHIAO-MEI LIU
臺大學術典藏 2020-03-05T06:28:37Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
國立臺灣大學 2015 Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations Liang, Yi-Hsin; Lin, Yu-Lin; Liau, Jau-Yu; Tsai, Jia-Huei; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Tseng, Li-Hui; Lin, Liang-In; Chang, Yih-Leong; Cheng, Ann-Lii; Yeh, Kun-Huei; 梁逸歆; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 蔡佳惠; 洪基翔; 林本仁; 廖肇裕; 梁金銅
臺大學術典藏 2018-09-10T15:21:53Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang, Y.-H. and Lin, Y.-L. and Liau, J.-Y. and Tsai, J.-H. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Tseng, L.-H. and Lin, L.-I. and Chang, Y.-L. and Cheng, A.-L. and Yeh, K.-H.; YIH-LEONG CHANG
臺大學術典藏 2018-09-10T15:23:10Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang, Y.-H. and Lin, Y.-L. and Liau, J.-Y. and Tsai, J.-H. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Tseng, L.-H. and Lin, L.-I. and Chang, Y.-L. and Cheng, A.-L. and Yeh, K.-H.; Jin-Tung Liang
臺大學術典藏 2018-09-10T15:23:29Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations JAU-YU LIAU; Liang, Y.-H. and Lin, Y.-L. and Liau, J.-Y. and Tsai, J.-H. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Tseng, L.-H. and Lin, L.-I. and Chang, Y.-L. and Cheng, A.-L. and Yeh, K.-H.
臺大學術典藏 2018-09-10T15:25:12Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang, Y.-H. and Lin, Y.-L. and Liau, J.-Y. and Tsai, J.-H. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Tseng, L.-H. and Lin, L.-I. and Chang, Y.-L. and Cheng, A.-L. and Yeh, K.-H.; Ji-Shiang Hung
臺大學術典藏 2020-02-25T05:15:25Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-07T06:56:23Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-06-16T07:53:31Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Liang-In Lin;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-05T07:31:46Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏 2020-03-06T05:26:12Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-05-03T02:20:55Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Jin-Tung Liang;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-05-07T02:46:37Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations YI-HSIN LIANG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-08-31T06:29:50Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏 2022-03-10T07:58:41Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; LI-HUI TSENG; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-01-28T01:06:29Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Kun-Huei Yeh; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; KUN-HUEI YEH
臺北醫學大學 2006 Cetuximab plus chemotherapy as salvage treatment for advanced colorectal cancer in Taiwanese: Experiences in Taipei Medical University Hospital 戴承正; Cheng-Jeng Tai; Chih-Hsiung Wu; Ching-Shyang Chen; Min-Ter Huang; Jeng-Feng Chiou; Chen-Jei Tai
臺北醫學大學 2006 Cetuximab plus chemotherapy as salvage treatment for advanced colorectal cancer in Taiwanese:Experiences in Taipei Medical University Hospital 吳志雄; 黃銘德; Tai CJ; Wu CH; Chen CS; Huang MT; Chiou JF; Tai CJ;
臺北醫學大學 2006 Cetuximab plus chemotherapy as salvage treatment for advanced colorectal cancer in Taiwanese;Experiences in Taipei Medical University Hospital 邱仲峰; C; J; Tai; C; H; Wu; C; S; Chen; M; T; Huang; J; F; Chiou; C; J; Tai
國立成功大學 2024--JAN Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08) Wang;Hung-Ming;Lou;Pei-Jen;Yang;Muh-Hwa;Chen;Tein-Hua;Lien;Ming-Yu;Lin;Jin-Ching;Chen;Jo-Pai;Lu;Wei-Chen;Lu;Hsueh-Ju;Huang;Tai-Lin;Yen;Chia-Jui;Wu;Shang-Yin;Wang;Hui-Ching;Hsieh;Meng-Che
高雄醫學大學 2007 Cetuximab合併化學治療於轉移性結直腸癌:表皮生長因子受器表現的角色  王照元 
中山醫學大學 2021 Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway Wu, TK; Ou, YC; Chen, YP; Huang, FM; Pan, YR; Lee, CJ
中山醫學大學 2021 Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-beta/Smad/miR-181b/TIMP3 Signaling Pathway Yue, CH; Chen, CH; Pan, YR; Chen, YP; Huang, FM; Lee, CJ
中山醫學大學 2020 Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells Via Inactivation of c-Met/PI3K/Akt/mTOR Pathway Yue, CH; Chen, CH; Lee, WT; Su, TF; Pan, YR; Chen, YP; Huang, FM; Lee, CJ
元智大學 Sep-23 Cetyltrimethylammonium Bromide Reformed Ceria Nanocomposites of Chemical Mechanical Planarization for Silica Wafer You-Sheng Lin; Kuen-Song Lin; Wei‒Chin Tsai; Ndumiso Vukile Mdlov; Cheng-Yang Tan; U-Ser Jeng
中山醫學大學 2020 Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor Signaling Wu, TK; Chen, CH; Lee, WT; Su, TF; Pan, YR; Huang, FM; Lee, CJ
義守大學 2008 CEV過程下美式回顧型選擇權的評價 童三峰; San-Feng Tong
臺大學術典藏 2018-09-10T03:46:05Z Cezanne: la serie de Chateau Noir 劉巧楣; CHIAO-MEI LIU; 劉巧楣
國立臺灣大學 2001-06 Cezanne: la serie de Chateau Noir 劉巧楣
中華大學 1998 CE認證專案研究-以醫療器材為例 許峻獻; HSUEN, HSU CHUN
淡江大學 2011-11-05 CF-002 Analysis, Synthesis and Design of a One-step Dimethyl Ether Production via a Thermodynamic Approach Chen, H.J.; C.W. Fan
臺大學術典藏 2022-06-21T23:24:24Z CF-NET: COMPLEMENTARY FUSION NETWORK FOR ROTATION INVARIANT POINT CLOUD COMPLETION Chen, Bo Fan; Yeh, Yang Ming; YI-CHANG LU
中原大學 2003-01 CF/sub 4//C/sub 2/H/sub 2/電漿聚合披覆非對稱性聚[石風]薄膜應用於滲透蒸發分離程序 CF/sub 4//C/sub 2/H/sub 2/ Plasma Deposition onto Asymmetric Polysulfone Membrane for Pervaporation Separation Process 方佩珊;杜振源;李魁然;賴君義
國立成功大學 2000 CF2Cl2及CFCl3在Si(111)(7X7)表面之光子及電子引發解離及脫附研究 溫清榕
國立成功大學 2004-07-24 CF3Br分子吸附在Si(111)-7×7之光電子 及光子激發脫附研究 謝育秦; Shai, Yi-Chyn
中原大學 2003-08-25 CF4 / C2H2電漿披覆於非對稱聚碸膜對滲透蒸發之影響 方珮珊; Pei-Shan Fang
大葉大學 2007-06-07 CF4 plasma pre-treatment catalyst effect on surface morphology and field emission properties of thermal chemical vapor deposited carbon nanotubes films Lee, Shih-Fong;Yeha, Kuo-Hui;Chang, Yung-Ping;Hsu, Po-Kai
國立交通大學 2014-12-08T15:37:03Z CF4 plasma treatment for fabricating high-performance and reliable solid-phase-crystallized poly-Si TFTs Wang, SD; Lo, WH; Lei, TF
臺大學術典藏 2018-09-10T05:54:08Z CF4 plasma treatment for preparing gas diffusion layers in membrane electrode assemblies HSIN-FU HUANG;Shieu, F.-S.;Zen, J.-M.;Lee, C.-M.;Huang, H.-F.;Ke, J.-H.;Pai, Y.-H.;HSIN-FU HUANG; Pai, Y.-H.; Ke, J.-H.; Huang, H.-F.; Lee, C.-M.; Zen, J.-M.; Shieu, F.-S.; HSIN-FU HUANG
國立交通大學 2014-12-08T15:06:31Z CF4 PLASMA-ETCHING ON LINBO3 LEE, CL; LU, CL
國立交通大學 2014-12-12T01:37:00Z CF4 電漿處理對可撓式聚對苯二甲酸乙二酯基材水氣穿透率之影響 賴伯政; Lai, Po-Cheng; 呂志鵬; Leu, Jih-perng
國立交通大學 2014-12-08T15:12:51Z CF4-plasma-induced fluorine passivation effects on poly-Si TFTs with high-kappa Pr2O3 gate dielectric Chang, Chia-Wen; Huang, Po-Wei; Deng, Chih-Kang; Huang, Jiun-Jia; Chang, Hong-Ren; Lei, Tan-Fu
中原大學 2003-1-17 CF4/C2H2 電漿聚合披覆非對稱性聚碸薄膜應用於滲透蒸發分離程序 方珮珊;杜振源;李魁然;賴君義;
中原大學 2003-1-17 CF4/C2H2 電漿聚合披覆非對稱性聚碸薄膜應用於滲透蒸發分離程序 方珮珊;杜振源;李魁然;賴君義;
國立成功大學 1995 CF4與Si單晶表面作用之研究 溫清榕
國立交通大學 2014-12-12T02:25:33Z CF4電漿前置處理在超大型積體電路上的相關應用 曾泓棋; Tzeng Hung Chi; 李崇仁; Lee Chung Len
國立臺灣海洋大學 2018 CF8鑄造不銹鋼及模擬熱影響區組織應力腐蝕特性研究 Chang, Hao Han; 張顥瀚
國立成功大學 2023 CFA: An explainable deep learning model for annotating the transcriptional roles of cis-regulatory modules based on epigenetic codes Yang, T.-H.;Yu, Yu Y.-H.;Wu, S.-H.;Zhang, F.-Y.

显示项目 244831-244880 / 2348487 (共46970页)
<< < 4892 4893 4894 4895 4896 4897 4898 4899 4900 4901 > >>
每页显示[10|25|50]项目